BLSH vs DOCN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

BLSH

63.7
AI Score
VS
BLSH Wins

DOCN

59.3
AI Score

Investment Advisor Scores

BLSH

64score
Recommendation
HOLD

DOCN

59score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric BLSH DOCN Winner
Forward P/E 37.037 42.1941 BLSH
PEG Ratio 0 1.5379 Tie
Revenue Growth 68.8% 39.9% BLSH
Earnings Growth 0.0% -24.5% BLSH
Tradestie Score 63.7/100 59.3/100 BLSH
Profit Margin 0.0% 3.1% DOCN
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

BLSH 1M: -29.8% · 3M: -9.9% DOCN 1M: -39.5% · 3M: -40.4%

Current Technical Phase

BLSH

Markdown
Sell / avoid

Price below a falling SMA50 (slope -1.4%), weak momentum, RSI 34

RSI (14): 33.9 · Price: $22.19

DOCN

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.9%), weak momentum, RSI 35

RSI (14): 34.5 · Price: $79.52

Fundamentals Snapshot

Metric BLSH DOCN
Market Cap — —
Forward P/E 7.4 40.4
Trailing P/E — 270.0
Revenue (TTM) — —
Revenue Growth 0.7% 0.4%
Gross Margin 1.0% 0.5%
Operating Margin -3.1% 0.1%
EPS -9.70 0.29
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, BLSH is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.